A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC). Phase II trial of intravenous carboplatin (C), ...
Figure 1. A 74-y-old man at initial staging with PSMA PET that demonstrates low uptake in primary tumor (A, arrowhead) and left pelvic side wall node (A, arrow). Bone scan was read as positive by 2 of ...
A biopsy is the only test that can confirm a cancer diagnosis. However, before doctors conduct a biopsy, they may take a person’s medical history, perform a physical exam, and order various imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results